Speaker illustration

Professor Mattias Duytschaever

St-Jan Hospital, Bruges (Belgium)

Write your professional biography here ...

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation?

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session type: Symposium

Thumbnail

Innovation in catheter ablation with real-time, temperature-controlled technology

Event: EHRA 2021

Topic: Catheter Ablation of Arrhythmias

Session type: Satellite Symposium

Thumbnail

Towards improved outcome of atrial ablation I

Event: EHRA 2021

Topic: Rhythm Control, Catheter Ablation

Session type: Abstract Sessions

Thumbnail

The new kids on the block - Mapping and ablation of atrial fibrillation in 2020

Event: EHRA 2019

Topic: Treatment

Session type: Symposium

Thumbnail

Closing the gap with high density mapping

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session type: Satellite Symposium

Thumbnail

Key determinants for durable lesions in atrial fibrillation

Event: EHRA 2018

Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Session type: Tutorials

Thumbnail

How can I get more than 90% success rate in Pulmonary Vein Isolation (PVI) for my atrial fibrillation patients

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

New technologies in catheter ablation of atrial fibrillation: toy or tool?

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Atrial fibrillation ablation

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk